R1 RCM (RCM) Prices 15M Share Secondary Offering at $22.50/Sh by Selling Shareholders
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 9/19/2026
- S&P 500, Nasdaq advance, turning the page on a tumultuous week
- Oil slides after China asks Iran to limit Houthi attacks on Saudi oil facilities
- Warren Buffett transitions to Berkshire’s chairman emeritus
- Is the S&P 500 in an "earnings bubble"? Goldman weighs in
- Wells Fargo cuts Netflix rating on engagement risk, weak slate
- S&P 500, Nasdaq advance, turning the page on a tumultuous week
- Wells Fargo Downgrades Netflix (NFLX) to Underweight on Engagement Risks, 'We see tougher choices ahead'
- Anthropic and Accenture partner on embedded AI safety evaluation
- Wells Fargo cuts Netflix rating on engagement risk, weak slate
- SanDisk stock rallies on AI optimism and Fed relief
Pre-Open Stock Movers 05/26: (NBRV) (PIRS) (GME) Higher; (LRMR) (LOTZ) (TVTX) Lower (more...)
May 26, 2021 9:23 AM EDTPre-Open Stock Movers:
Nabriva Therapeutics (NASDAQ: NBRV) 49.3% HIGHER; Sinovant Sciences, a Chinese biopharmaceutical company dedicated to conducting innovative biomedical R&D in China, and Nabriva Therapeutics (NASDAQ: NBRV), a biopharmaceutical company engaged in the commercialization and development of innovative anti-infective agents to treat serious infections, today announced positive topline results from Sinovants Phase 3 bridging study of lefamulin in Chinese adults with community acquired bacterial pneumonia (CABP).
R1 RCM (RCM) Announces Proposed 15M Share Secondary Offering by Selling Shareholders
May 26, 2021 6:11 AM EDTR1 RCM Inc. (NASDAQ: RCM) announced the commencement of an underwritten offering of an aggregate of 15,000,000 shares of its common stock by selling stockholders. The selling stockholders are TCP-ASC ACHI Series LLLP (TCP-ASC), a Delaware series limited liability limited partnership jointly owned by Ascension Health... More
